Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00573183 · ClinicalTrials.gov registry record · Phase 3
Stimulant Abuser Groups to Engage in 12-Step
A Phase 3 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 3
- Development phase
- 471
- Enrollment target
NCT00573183 is a Phase 3 study that has completed, run by University of Washington. The registered enrollment target is 471 participants.
The verdict
NCT00573183, a Phase 3 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 471 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a combined group and individual 12-Step facilitative (TSF) intervention, Stimulant Abuser Groups to Engage in 12 -Step (STAGE-12), improves substance -related outcomes.
Interventions
- BEHAVIORAL Treatment as Usual
- BEHAVIORAL STAGE-12
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 471 participants |
| Start Date | 2008-01 |
| Est. Completion | 2010-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00573183
The ClinicalTrials.gov registry entry for NCT00573183 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 471 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Treatment as Usual is the first listed.
NCT00573183 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00573183 about?
NCT00573183 is a clinical study titled "Stimulant Abuser Groups to Engage in 12-Step". The purpose of this study is to determine whether a combined group and individual 12-Step facilitative (TSF) intervention, Stimulant Abuser Groups to Engage in 12 -Step (STAGE-12), improves substance -related outcomes.
What is the current status of trial NCT00573183?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 471 participants. The study started on 2008-01. Estimated completion is 2010-04.
What interventions are being tested in trial NCT00573183?
The interventions under investigation include: Treatment as Usual (BEHAVIORAL), STAGE-12 (BEHAVIORAL).
Who is sponsoring clinical trial NCT00573183?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.